Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Interplay effect on a 6-MV flattening-filter-free linear accelerator with high dose rate and fast multi-leaf collimator motion treating breast and lung phantoms.

Netherton T, Li Y, Nitsch P, Shaitelman S, Balter P, Gao S, Klopp A, Muruganandham M, Court L.

Med Phys. 2018 Jun;45(6):2369-2376. doi: 10.1002/mp.12899. Epub 2018 Apr 24.

PMID:
29611210
2.

Environmental Applications of ZnO Materials.

Muruganandham M, Zhang Y, Suri R, Lee GJ, Chen PK, Hsieh SH, Sillanpää M, Wu JJ.

J Nanosci Nanotechnol. 2015 Sep;15(9):6900-13.

PMID:
26716262
3.

Synthesis, Characterization of α-GaOOH Self-Assembly and Its Application in Removal of Perfluorinated Compounds.

Muruganandham M, Suri RP, Abdel Wahed MS, Sillanpää M, Wu JJ, Ahmmad B.

J Nanosci Nanotechnol. 2015 Sep;15(9):6524-32.

PMID:
26716208
4.

3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.

Muruganandham M, Clerkin PP, Smith BJ, Anderson CM, Morris A, Capizzano AA, Magnotta V, McGuire SM, Smith MC, Bayouth JE, Buatti JM.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):181-9. doi: 10.1016/j.ijrobp.2014.05.014. Epub 2014 Jun 28.

5.

Recent developments in heterogeneous catalyzed environmental remediation processes.

Muruganandham M, Suri RP, Sillanpää M, Wu JJ, Ahmmad B, Balachandran S, Swaminathan M.

J Nanosci Nanotechnol. 2014 Feb;14(2):1898-910. Review.

PMID:
24749464
6.

Development of high efficiency silica coated β-cyclodextrin polymeric adsorbent for the removal of emerging contaminants of concern from water.

Bhattarai B, Muruganandham M, Suri RP.

J Hazard Mater. 2014 May 30;273:146-54. doi: 10.1016/j.jhazmat.2014.03.044. Epub 2014 Mar 31.

PMID:
24727017
7.

Fabrication and photocatalytic properties of self-assembled in(OH)3 and In2O3 nano/micro-cubes.

Muruganandham M, Sillanpää ME, Suri RP, Lee GJ, Wu JJ, Ahmad B, Kuroda Y.

J Nanosci Nanotechnol. 2013 Mar;13(3):1639-48.

PMID:
23755569
8.

Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.

Schindel J, Muruganandham M, Pigge FC, Anderson J, Kim Y.

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):387-93. doi: 10.1016/j.ijrobp.2012.12.026. Epub 2013 Feb 20.

PMID:
23433797
9.

Disinfection of water using Pt- and Ag-doped TiO2 photocatalysts.

Suri RP, Thornton HM, Muruganandham M.

Environ Technol. 2012 Jul-Aug;33(13-15):1651-9.

PMID:
22988625
10.

Image-Based Treatment Planning of the Post-Lumpectomy Breast Utilizing CT and 3TMRI.

Jacobson G, Zamba G, Betts V, Muruganandham M, Buechler-Price J.

Int J Breast Cancer. 2011;2011:246265. doi: 10.4061/2011/246265. Epub 2011 Apr 6.

11.

Facile microwave-combustion synthesis of wurtzite CdS nanoparticles.

Amutha R, Muruganandham M, Lee GJ, Wu JJ.

J Nanosci Nanotechnol. 2011 Sep;11(9):7940-4.

PMID:
22097510
12.

Template-free synthesis of self-assembled Co3O4 micro/nanocrystals.

Amutha R, Akilandeswari S, Muruganandham M, Sillanpää M, Ahmmad B, Ohkubo T.

J Nanosci Nanotechnol. 2011 Apr;11(4):3171-9.

PMID:
21776684
13.

Image-based biomarkers in clinical practice.

Bayouth JE, Casavant TL, Graham MM, Sonka M, Muruganandham M, Buatti JM.

Semin Radiat Oncol. 2011 Apr;21(2):157-66. doi: 10.1016/j.semradonc.2010.11.003. Review.

14.

Template-free synthesis of beta-In2S3 superstructures and their photocatalytic activity.

Amutha R, Akilandeswari S, Ahmmad B, Muruganandham M, Sillanpää M.

J Nanosci Nanotechnol. 2010 Dec;10(12):8438-47.

PMID:
21121351
15.

Are dopant-stabilized visible light-responsive photocatalysts efficient and stable?

Muruganandham M, Ramakrishnan A, Kusumoto Y, Sillanpää M.

Phys Chem Chem Phys. 2010 Nov 28;12(44):14677-81. doi: 10.1039/c0cp01033b. Epub 2010 Oct 13.

PMID:
20944838
16.

Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer.

Kim Y, Muruganandham M, Modrick JM, Bayouth JE.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):947-55. doi: 10.1016/j.ijrobp.2010.07.1981. Epub 2010 Oct 8.

PMID:
20934275
17.

Reagents for ZnS hierarchical and non-hierarchical porous self-assembly.

Muruganandham M, Amutha R, Sillanpää M.

ACS Appl Mater Interfaces. 2010 Jul;2(7):1817-23. doi: 10.1021/am100390u.

PMID:
20565130
18.

Effect of temperature on the formation of macroporous ZnO bundles and its application in photocatalysis.

Muruganandham M, Chen IS, Wu JJ.

J Hazard Mater. 2009 Dec 30;172(2-3):700-6. doi: 10.1016/j.jhazmat.2009.07.053. Epub 2009 Jul 22.

PMID:
19665842
19.
20.

Degradation of DMSO by ozone-based advanced oxidation processes.

Wu JJ, Muruganandham M, Chen SH.

J Hazard Mater. 2007 Oct 1;149(1):218-25. Epub 2007 Mar 27.

PMID:
17467897
21.

A comparative study of quantum yield and electrical energy per order (E(Eo)) for advanced oxidative decolourisation of reactive azo dyes by UV light.

Muruganandham M, Selvam K, Swaminathan M.

J Hazard Mater. 2007 Jun 1;144(1-2):316-22. Epub 2006 Oct 15.

PMID:
17125921
22.

Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.

Muruganandham M, Lupu M, Dyke JP, Matei C, Linn M, Packman K, Kolinsky K, Higgins B, Koutcher JA.

Mol Cancer Ther. 2006 Aug;5(8):1950-7.

23.

Solar assisted photocatalytic and photochemical degradation of Reactive Black 5.

Muruganandham M, Sobana N, Swaminathan M.

J Hazard Mater. 2006 Oct 11;137(3):1371-6. Epub 2006 May 15.

PMID:
16704898
24.

TiO2-UV photocatalytic oxidation of Reactive Yellow 14: effect of operational parameters.

Muruganandham M, Swaminathan M.

J Hazard Mater. 2006 Jul 31;135(1-3):78-86. Epub 2006 Jan 18.

PMID:
16386844
25.

Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.

Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I, Hasmann M, Saltz LB, Koutcher JA.

Clin Cancer Res. 2005 May 1;11(9):3503-13.

26.

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.

Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, Muruganandham M, Ebora L, Kattan MW, Reuter VE, Scardino PT, Koutcher JA.

Radiology. 2005 Mar;234(3):804-14.

PMID:
15734935
27.

In vivo tumor lactate relaxation measurements by selective multiple-quantum-coherence (Sel-MQC) transfer.

Muruganandham M, Koutcher JA, Pizzorno G, He Q.

Magn Reson Med. 2004 Oct;52(4):902-6. Erratum in: Magn Reson Med. 2005 Feb;53(2):491.

28.

Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations.

Shukla-Dave A, Hricak H, Eberhardt SC, Olgac S, Muruganandham M, Scardino PT, Reuter VE, Koutcher JA, Zakian KL.

Radiology. 2004 Jun;231(3):717-24.

PMID:
15163811
29.

Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.

Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT, Koutcher JA.

Radiology. 2003 Oct;229(1):241-7. Epub 2003 Aug 14.

PMID:
12920178
30.

Diltiazem enhances tumor blood flow: MRI study in a murine tumor.

Muruganandham M, Kasiviswanathan A, Jagannathan NR, Raghunathan P, Jain PC, Jain V.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):413-21.

PMID:
10030270
31.

Binding of monomeric and oligomeric porphyrins to human glioblastoma (U-87MG) cells and their photosensitivity.

Sreenivasan R, Muruganandham M, Sharma M, Joshi PG, Joshi NB.

Cancer Lett. 1997 Nov 25;120(1):45-51.

PMID:
9570385

Supplemental Content

Loading ...
Support Center